DNA fragmentation in mouse organs during endotoxic shock

American Journal of Pathology

Volumn 149, Issue 4, 1996, Pages 1381-1393

  Bohlinger, Ines ^a   Leist, Marcel ^a   Gantner, Florian ^a   Angermüller, Sabine ^b   Tiegs, Gisa ^a   Wendel, Albrecht ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA FRAGMENT; ENDOTOXIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CYTOTOXICITY; FEMALE; IMMUNE RESPONSE; INFLAMMATION; LIVER CELL; LIVER FAILURE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0029822925     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Darville T, Giroir B, Jacobs R: The systemic inflammatory response syndrome (SIRS): immunology potential immunotherapy. Infection 1993, 21:279-290
2. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA: Sepsis syndrome: a valid clinical entity. Crit Care Med 1989, 17:389-393
3. Bone RC: The pathogenesis of sepsis. Ann Intern Med 1991, 115:457-469
4. Redl H, Bahrami S, Schlag G, Traber DL: Clinical detection of LPS and animal models of endotoxemia. Immunobiology 1993, 187:330-345
5. Natanson C, Eichenholz PW, Danner RL, Eichacker PQ, Hoffman WD, Kuo GC, Banks SM, Mac Vittie TJ, Parrillo JE: Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989, 169:823-832
6. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RMH, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655
7. Ohno Y, Shiga J, Mori W: Selective segmental hepatic necrosis produced by the Shwartzman mechanism in rabbits. Virchows Arch A Pathol Anat Histol 1989, 416: 75-80
8. Billiar TR, Curran RD, Harbrecht BG, Stuehr DJ, Demetris AJ, Simmons RL: Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukocyte Biol 1990, 48: 565-569
9. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie Q.-W, Sokol K, Hutchinson N, Chen H, Mudgett S: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995, 81:641-650
10. Wendel A: Biochemical pharmacology of inflammatory liver injury in mice. Methods Enzymol 1990, 186:675-680
11. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995, 146:1220-1234
12. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987, 330:662-664
13. Kilbourn RG, Gross SS, Jubran A, Adams J, Griffith OW, Levi R, Lodato RF: NG-methyl-[scapl-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990, 87:3629-3632
14. Nava E, Palmer RMJ, Moncada S: Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 1991, 338:1555-1557
15. Petros A, Bennett D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991, 338:1557-1558
16. Bohlinger I, Leist M, Barsig J, Uhlig S, Tiegs G, Wendel A: Interleukin-1 and nitric oxide protect against tumor necrosis factor-α-induced liver injury through distinct pathways. Hepatology 1995, 22:1829-1837
17. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985, 229:869-871
18. Mathison JC, Wolfson E, Ulevitch RJ: Participation of tumor necrosis factor in the mediation of Gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 1988, 1937, 81:1925
19. Rothe J, Lesslauer W, Loetscher H, Lang Y, Koebel P, Köntgen F, Althage R, Zinkernagel R, Steinmetz M, Bluethmann H: Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993, 364:798-800
20. Waage A: Presence and involvement of TNF in septic shock. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. Edited by B Beutler. New York, Raven Press, 1993, pp 275-283
21. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A: Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol 1994, 153:1778-1788
22. Tiegs G, Wolter M, Wendel A: Tumor necrosis factor is a terminal mediator in D-galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 1989, 37:627-631
23. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG: A fluorimetric assay for the measurement of nitrite in biological samples. Anal Biochem 1993, 214:11-16
24. Bergmeyer HU: Methods of Enzymatic Analysis, ed 3. Weinheim, Germany, Verlag Chemie, 1984
25. Angermüller S, Schunk M, Kusterer K: Alteration of xanthine oxidase activity in sinusoidal endothelial cells and morphological changes of Kupffer cells in hypoxic and reoxygenated rat liver. Hepatology 1995, 21: 1594-1601
26. Oberhammer F, Bursch W, Tiefenbacher R, Fröschl G, Pavelka M, Purchio T, Schulte-Hermann R: Apoptosis is induced by transforming growth factor-β1 within 5 hours in regressing liver without significant fragmentation of the DNA. Hepatology 1993, 18:1238-1246
27. Boler RK, Bibighaus AJ, Brunson JG: An electron microscopic study of the liver of endotoxin-shocked dogs treated with a combination of propiomazine and levarterenol. Lab Invest 1969, 20:319-325
28. Hewett JA, Jean PA, Kunkel SL, Roth RA: Relationship between tumor necrosis factor-α and neutrophils in endotoxin-induced liver injury. Am J Physiol 1993, 265: G1011-G1015
29. Harbrecht BG, Billiar TR, Stadler AJ, Demetris AJ, Ochoa DJ, Curran RD, Simmons RL: Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 1992, 20:1568-1574
30. Portoles MT, Ainaga MJ, Pagani R: The induction of lipid peroxidation by E coli lipopolysaccharide on rat hepatocytes as an important factor in the etiology of endotoxic liver damage. Biochim Biophys Acta 1993, 1158:287-292
31. Tiegs G, Wendel A: Leukotriene-mediated liver injury. Biochem Pharmacol 1988, 37:2569-2573
32. Wei X-Q, Charles IG, Smith A, Ure J, Feng G-J, Huang F-P, Xu D, Muller W, Moncada S, Liew FY: Altered immune response in mice lacking inducible nitric oxide synthase. Nature 1995, 375:408-411
33. Jin H, Yang R, Marsters SA, Bunting SA, Wurm FM, Chamow SM, Ashkenazi A: Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody. J Infect Dis 1994, 170:1323-1326
34. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874
35. Schlag G, Redl H, Hallström S: The cell in shock: the origin of multiple organ failure. Resuscitation 1991, 21: 137-180
36. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA: Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995, 92: 7162-7166
37. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P: Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995, 15:961-973
38. Dypbukt JM, Ankarcrona M, Burkitt M, Sjöholm A, Ström K, Orrenius S, Nicotera P: Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. J Biol Chem 1994, 269:30553-30560
39. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R: In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995, 21: 1465-1468
40. 2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J 1993, 7:453-463
41. Fukuda K, Kojiro W, Chiu J: Demonstration of extensive chromatin cleavage in transplanted Morris hepatoma 7777 tissue: apoptosis or necrosis?. Am J Pathol 1993, 142:935-946
42. Collins RJ, Harmon BV, Gobe GC, Kerr JFR: Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radial Biol 1992, 61:451-453
43. Maeda K, Abello PA, Abraham MR, Wetzel RC, Robotham JL, Buchman TG: Endotoxin induces organ-specific endothelial cell injury. Shock 1995, 3:46-50
44. Abello PA, Fidler SA, Bulkley GB, Buchman TG: Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Arch Surg 1994, 129:134-141
45. Buchman TG, Abello PA, Smith EH, Bulkley GB: Induction of heat shock response leads to apoptosis in endothelial cells previously exposed to endotoxin. Am J Physiol 1993, 265:H165-H170
46. Polunovsky VA, Wendt CH, Ingbar DH, Peterson MS, Bitterman PB: Induction of endothelial cell apoptosis by TNF-α: modulation by inhibitors of protein synthesis. Exp Cell Res 1994, 214:584-594
47. Robaye B, Mosseimans R, Fiers W, Dumont JE, Galand P: Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 1991, 138:447-453
48. Squier MK, Sehnert AJ, Cohen JJ: Apoptosis in leukocytes. J Leukocyte Biol 1995, 57:2-10
49. Munn DH, Beall AC, Song D, Wrenn RW, Throckmorton DC: Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon-γ. J Exp Med 1995, 181:127-136
50. Levi M, ten Cate H, van der Poll T, van Deventer SJH: Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993, 270:975-979
51. Harbrecht BG, Billiar TR, Stadler AJ, Ochoa DJ, Curran RD, Simmons RL: Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukocyte Biol 1992, 52:390-394
52. Clancy RM, Leszczynska-Piziak J, Abramson SB: Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil Superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992, 90:1116-1121
53. Radomski MW, Palmer RM, Moncada S: An L-arginine/ nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1987, 87: 5193-5197
54. Natanson C, Huffman WD, Suffredini AF, Eichacker PQ, Danner RL: Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis, Ann Intern Med 1994, 120:771-783
55. Cobb JP, Natanson C, Quezado ZM N, Hoffman WD, Koev CA, Banks S, Correa R, Levi R, Elin RJ, Hosseini JM, Danner RL: Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol 1995, 268:H1634-H1642
56. Vary TC, Kimball SR: Regulation of protein synthesis in chronic inflammation and sepsis. Am J Physiol 1992, 262:C445-C452
57. Tate RM, Repine JE: Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 1983, 128:552-559
58. Heflin AC Jr, Brigham KL: Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest 1981, 68: 1253-1260
59. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr: Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990, 85:1936-1943
60. Hsueh W, Gonzalez-Crussi F, Arroyave JL: Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1987, 1:403-405
61. Terashita Z, Imura Y, Nishikawa K, Sumida S: Is platelet activating factor (PAF) a mediator of endotoxic shock? Eur J Pharmacol 1985, 109:257-261
62. Toth PD, Mikulaschek AW: Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat. Circ Shock 1986, 20:193-203